AEGON Asset Management (UK)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $150M | Sell |
1,169,722
-104,784
| -8% | -$12.3M | 1.6% | 16 |
|
|
2026
Q1 | $153M | Sell |
1,274,506
-25,252
| -2% | -$2.92M | 2.03% | 11 |
|
|
2025
Q4 | $137M | Buy |
1,299,758
+37,433
| +3% | +$3.51M | 1.63% | 11 |
|
|
2025
Q3 | $105M | Sell |
1,262,325
-70,398
| -5% | -$5.8M | 1.25% | 14 |
|
|
2025
Q2 | $105M | Buy |
1,332,723
+91,199
| +7% | +$7.25M | 1.35% | 15 |
|
|
2025
Q1 | $111M | Buy |
1,241,524
+235,575
| +23% | +$22M | 1.62% | 11 |
|
|
2024
Q4 | $100M | Sell |
1,005,949
-155,472
| -13% | -$16M | 1.32% | 13 |
|
|
2024
Q3 | $132M | Sell |
1,161,421
-54,706
| -4% | -$6.5M | 1.8% | 8 |
|
|
2024
Q2 | $151M | Sell |
1,216,127
-444,373
| -27% | -$57.2M | 2.12% | 7 |
|
|
2024
Q1 | $219M | Sell |
1,660,500
-55,168
| -3% | -$6.8M | 3.28% | 6 |
|
|
2023
Q4 | $187M | Buy |
+1,715,668
| New | +$178M | 2.98% | 6 |
|
|
2023
Q2 | $185M | Buy |
1,607,660
+472,603
| +42% | +$53.7M | 3% | 5 |
|
|
2023
Q1 | $121M | Sell |
1,135,057
-114,822
| -9% | -$12.4M | 2.11% | 8 |
|
|
2022
Q4 | $139M | Hold |
1,249,879
| – | – | 2.5% | 4 |
|
|
2022
Q3 | $108M | Sell |
1,249,879
-172,486
| -12% | -$15.4M | 2.18% | 9 |
|
|
2022
Q2 | $130M | Buy |
1,422,365
+138,143
| +11% | +$12.2M | 2.45% | 6 |
|
|
2022
Q1 | $105M | Buy |
1,284,222
+926,408
| +259% | +$73M | 1.56% | 14 |
|
|
2021
Q4 | $27.4M | Sell |
357,814
-21,940
| -6% | -$1.75M | 0.35% | 76 |
|
|
2021
Q3 | $28.5M | Buy |
379,754
+4,634
| +1% | +$352K | 0.41% | 76 |
|
|
2021
Q2 | $29.2M | Sell |
375,120
-48,666
| -11% | -$3.62M | 0.41% | 77 |
|
|
2021
Q1 | $31.2M | Sell |
423,786
-185,445
| -30% | -$13.7M | 0.46% | 70 |
|
|
2020
Q4 | $47.5M | Buy |
+609,231
| New | +$46.6M | 0.7% | 48 |
|
|
2018
Q4 | – | Sell |
-18,987
| Closed | -$1.28M | – | 186 |
|
|
2018
Q3 | $1.28M | Buy |
+18,987
| New | +$1.21M | 0.03% | 151 |
|
|
2018
Q2 | – | Sell |
-869,475
| Closed | -$45.2M | – | 183 |
|
|
2018
Q1 | $45.2M | Sell |
869,475
-34,842
| -4% | -$1.88M | 1.16% | 31 |
|
|
2017
Q4 | $48.6M | Sell |
904,317
-16,953
| -2% | -$940K | 1.23% | 33 |
|
|
2017
Q3 | $56.3M | Sell |
921,270
-15,219
| -2% | -$923K | 1.54% | 25 |
|
|
2017
Q2 | $57.3M | Sell |
936,489
-586,383
| -39% | -$35.7M | 1.61% | 23 |
|
|
2017
Q1 | $92.3M | Buy |
1,522,872
+151,290
| +11% | +$9.18M | 2.48% | 9 |
|
|
2016
Q4 | $77M | Buy |
1,371,582
+421,474
| +44% | +$24.7M | 2.18% | 12 |
|
|
2016
Q3 | $56.6M | Buy |
950,108
+5,698
| +0.6% | +$333K | 1.59% | 26 |
|
|
2016
Q2 | $51.9M | Sell |
944,410
-4,784
| -0.5% | -$255K | 1.49% | 26 |
|
|
2016
Q1 | $47.9M | Sell |
949,194
-1,900
| -0.2% | -$93.1K | 1.44% | 28 |
|
|
2015
Q4 | $47.9M | Sell |
951,094
-561,502
| -37% | -$28.3M | 1.4% | 25 |
|
|
2015
Q3 | $71.2M | Sell |
1,512,596
-2,414
| -0.2% | -$128K | 2.16% | 13 |
|
|
2015
Q2 | $82.3M | Sell |
1,515,010
-533,320
| -26% | -$29.9M | 2.28% | 12 |
|
|
2015
Q1 | $112M | Buy |
2,048,330
+1,821,488
| +803% | +$103M | 2.95% | 7 |
|
|
2014
Q4 | $12.3M | Sell |
226,842
-6,385
| -3% | -$356K | 1.36% | 22 |
|
|
2014
Q3 | $13.2M | Sell |
233,227
-894
| -0.4% | -$50.2K | 1.5% | 19 |
|
|
2014
Q2 | $12.9M | Buy |
234,121
+14,521
| +7% | +$792K | 1.48% | 19 |
|
|
2014
Q1 | $11.9M | Buy |
219,600
+19,592
| +10% | +$1.01M | 1.37% | 19 |
|
|
2013
Q4 | $9.55M | Buy |
200,008
+115,118
| +136% | +$5.26M | 1.36% | 18 |
|
|
2013
Q3 | $3.86M | Sell |
84,890
-5,541
| -6% | -$253K | 0.85% | 16 |
|
|
2013
Q2 | $4.01M | Buy |
+90,431
| New | +$4.04M | 0.94% | 16 |
|
Other funds holding MRK
ATO
QP
AEGON Asset Management (UK)'s MRK Position: Q2 2026 in Review
AEGON Asset Management (UK) reduced its Merck (MRK) stake by 8.2% in Q2 2026, selling an estimated $12.3M and leaving 1,169,722 shares worth $150M. The position accounts for 1.6% of the portfolio, ranked #16.
AEGON Asset Management (UK) first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $219M in Q1 2024. 1,429 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- AEGON Asset Management (UK) held 1,169,722 shares of Merck worth $150M as of Q2 2026.
- AEGON Asset Management (UK) sold 104,784 Merck shares in Q2 2026, an estimated $12.3M.
- Merck made up 1.6% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #16 holding.
- AEGON Asset Management (UK) first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
- AEGON Asset Management (UK)'s Merck position peaked at $219M in Q1 2024.
- 1,429 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.